Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102734 · ClinicalTrials.gov registry record

Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
44
Enrollment target

NCT05102734: Completed study, sponsored by University of Pennsylvania.

NCT05102734 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102734 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
44 participants
Enrollment target

Study Summary

This is an open-label, single center, trial that will enroll up to 25 participants with circulatory shock after cardiac surgery. Participants will be administered a topical sublingual nitroglycerin solution and assessed for changes microcirculatory blood flow using incident dark field microscopy.

Interventions

  • DRUG Nitroglycerin Topical Product

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2021-09-01
Est. Completion 2022-03-01

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05102734

The ClinicalTrials.gov registry entry for NCT05102734 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Nitroglycerin Topical Product is the first listed.

NCT05102734 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05102734 about?

NCT05102734 is a clinical study titled "Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.". This is an open-label, single center, trial that will enroll up to 25 participants with circulatory shock after cardiac surgery. Participants will be administered a topical sublingual nitroglycerin solution and assessed for changes microcirculatory blood flow using incident dark field microscopy.

What is the current status of trial NCT05102734?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2021-09-01. Estimated completion is 2022-03-01.

What interventions are being tested in trial NCT05102734?

The interventions under investigation include: Nitroglycerin Topical Product (DRUG).

Who is sponsoring clinical trial NCT05102734?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.